Back to announcement
20240912_SCPI_Tanggapan atas Permintaan Penjelasan Bursa_31725589_lamp1.pdf
Other Text extracted SCPISource file signed link, expires in 15 minutes
Extracted text 2
Page 1
Sinarmas MSIG Tower 37th floor unit 102-106
Jl. Jend. Sudirman Kav 21
Karet, Setiabudi, Jakarta Selatan,
DKI Jakarta 12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
No. 092/OPI/IX/2024 Jakarta, 5 September 2024
Kepada Yth./ To:
Bursa Efek Indonesia / Indonesia Stock Exchange (“BEI”)
Indonesia Stock Exchange Building,
Tower I, 6th Floor,
Jl. Jend. Sudirman Kav.52-53, Jakarta 12190 – Indonesia
U.p./Attn: Kepala Divisi Penilaian Perusahaan 3 / Head of Company Assessment Division 3
Perihal: Penyampaian Tanggapan atas Surat Subject: Response Submission to BEI’s Letter
BEI sehubungan dengan Permintaan concerning Request for Explanation of PT
Penjelasan PT Organon Pharma Indonesia Tbk Organon Pharma Indonesia Tbk
Dengan hormat, Dear Madam,
Merujuk surat BEI No. S-09297/BEI.PP3/09-2024 Referring to BEI’s letter No. S-09297/BEI.PP3/09-
tanggal 3 September 2024 tentang Permintaan 2024 dated 3 September 2024 regarding Request
Penjelasan PT Organon Pharma Indonesia Tbk for Explanation of PT Organon Pharma Indonesia
(“Surat BEI”) yang ditujukan kepada PT Organon Tbk (“BEI’s Letter”) addressed to PT Organon
Pharma Indonesia Tbk (“Perseroan”), bersama Pharma Indonesia Tbk (“Company”), with this
dengan surat ini Perseroan bermaksud untuk letter the Company intends to submit the
memberikan beberapa tanggapan atas Surat BEI explanation to the pertaining BEI’s letter.
tersebut.
Adapun yang dapat kami berikan klarifikasi saat At this point of time, Company will give clarification
ini ; for ;
1. Perkembangan proses Voluntary Delisting dan 1. Update on the Voluntary Delisting or Go Private
Go Private Perseroan
a. Saat ini jumlah pemegang saham a. As of now, the number of Company’s
belum memenuhi minimal kuota shareholders has not yet met the required
ambang batas yang dipersyaratkan threshold to proceed with the application for
untuk melanjutkan permohonan the withdrawal of the effective letter from
pencabutan surat efektif dari OJK. OJK. Therefore, Company is currently
Perseroan sedang merumuskan working on formulating alternative
pendekatan alternatif untuk memenuhi approaches to meet the applicable
persyaratan yang berlaku. requirements.
Demikian tanggapan yang dapat kami sampaikan. Thus we convey this clarification. Thank you for
Atas perhatiannya, kami mengucapkan terima your kind attention.
kasih.
Page 2
Sinarmas MSIG Tower 37th floor unit 102-106
Jl. Jend. Sudirman Kav 21
Karet, Setiabudi, Jakarta Selatan,
DKI Jakarta 12920
Phone No (62) 21-31107000
Fax No (62) 21-31107009
Hormat Kami/Best Regards
PT Organon Pharma Indonesia Tbk
Nama/Name: Daniel
Jabatan/Title: President Director
Names mentioned 7 people and organisations named in the text · linked when the evidence is strong
unresolved
org
Indonesia Stock Exchange
p.1 ×2
unresolved
org
Pharma Indonesia Tbk
p.1
unresolved
person
Nama/Name: Daniel
· Jabatan/Title: President Director
p.2
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.